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Prostatic acid phosphatase (PAP) and ecto-5-nucleotidase (NT5E) hydrolyze extracellular AMP to adenosine in dorsal root ganglia
(DRG) neurons and in the dorsal spinal cord. Previously, we found that adenosine production was reduced, but not eliminated, in
Pap  / /Nt5e  /  double knock-out (dKO) mice, suggesting that a third AMP ectonucleotidase was present in these tissues. Here, we
found that tissue-nonspecific alkaline phosphatase (TNAP, encoded by the Alpl gene) is expressed and functional in DRG neurons and
spinal neurons. Using a cell-based assay, we found that TNAP rapidly hydrolyzed extracellular AMP and activated adenosine receptors.
This activity was eliminated by MLS-0038949, a selective pharmacological inhibitor of TNAP. In addition, MLS-0038949 eliminated AMP
hydrolysis in DRG and spinal lamina II of dKO mice. Using fast-scan-cyclic voltammetry, we found that adenosine was rapidly produced
from AMP in spinal cord slices from dKO mice, but virtually no adenosine was produced in spinal cord slices from dKO mice treated with
MLS-0038949. Last, we found that AMP inhibited excitatory neurotransmission via adenosine A1 receptor activation in spinal cord slices
from wild-type, Pap  / , Nt5e  / , and dKO mice, but failed to inhibit neurotransmission in slices from dKO mice treated with MLS-
0038949. These data suggest that triple elimination of TNAP, PAP, and NT5E is required to block AMP hydrolysis to adenosine in DRG
neurons and dorsal spinal cord. Moreover, our data reveal that TNAP, PAP, and NT5E are the main AMP ectonucleotidases in primary
somatosensory neurons and regulate physiology by metabolizing extracellular purine nucleotides.
Introduction
Ectonucleotidases regulate diverse physiological functions by hy-
drolyzing extracellular nucleotides such as ATP, ADP, and AMP
(Picher et al., 2003; Zimmermann, 2006a; Schetinger et al., 2007;
St Hilaire et al., 2011; Zylka, 2011). Recently, we identified two
ectonucleotidases, prostatic acid phosphatase (PAP) and ecto-5-
nucleotidase (NT5E), that are expressed in small-diameter, pre-
sumably nociceptive, dorsal root ganglia (DRG) neurons (Zylka
et al., 2008; Sowa et al., 2010a). These enzymes hydrolyze AMP to
adenosine in DRG neurons and their spinal axon terminals
(Zylka et al., 2008; Sowa et al., 2010a). In addition, PAP and
NT5E inhibit excitatory neurotransmission in the dorsal spinal
cord and inhibit nociceptive responses at the behavioral level by
acting through the adenosine A1 receptor (A1R; Sowa et al., 2009;
Sowa et al., 2010b; Street et al., 2011). Our research thus revealed
roles for PAP and NT5E in reducing pain-related physiological
and behavioral responses. Intriguingly, we also found that genetic
deletion of PAP and NT5E using Pap / /Nt5e /  double
knock-out (dKO) mice reduced, but did not eliminate, the pro-
duction of adenosine from extracellular AMP, suggesting that at
least one additional AMP ectonucleotidase was present in DRG
neurons and spinal cord (Street et al., 2011).
In this study, we sought to ascertain the molecular identity of
this third AMP ectonucleotidase. Using multiple approaches, in-
cluding histochemistry, fast-scan-cyclic voltammetry (FSCV),
and electrophysiology, we found that tissue-nonspecific alkaline
phosphatase (TNAP; also known as liver/bone/kidney alkaline
phosphatase) is this third enzyme. TNAP is an extracellularly
active, glycophosphatidylinositol-anchored membrane protein
that hydrolyzes several different molecules at physiological (neu-
tral) and alkaline pH, including nucleotides (Scheibe et al., 2000;
Zimmermann, 2006b; Ciancaglini et al., 2010), pyridoxal-5
phosphate (the active form of vitamin B6) and inorganic pyro-
phosphate (Millán, 2006a). Inorganic pyrophosphate is a potent
bone mineralization inhibitor and accumulates in TNAP-
Received Jan. 10, 2013; revised May 29, 2013; accepted June 4, 2013.
Author contributions: S.E.S., N.J.K., P.L.W., and M.J.Z. designed research; S.E.S., N.J.K., P.L.W., B.T.-B., and I.F.K.
performed research; M.C.Y., P.V., R.M.W., and J.L.M. contributed unpublished reagents/analytic tools; S.E.S., N.J.K.,
P.L.W., B.T.-B., I.F.K., and M.J.Z. analyzed data; S.E.S. and M.J.Z. wrote the paper.
This work was supported by the National Institute of Neurological Disorders and Stroke–National Institutes of
Health (Grant #R01NS067688 to M.J.Z.), the National Institute of Dental and Craniofacial Research–National Insti-
tutes of Health (Grant #R01 DE012889 to J.L.M.), and the National Institutes of Health (Grant #R01NS038879 to
R.M.W.). The In Situ Hybridization Core is funded by the National Institute of Neurological Disorders and Stroke–
National Institutes of Health (Grant #P30NS045892) and the National Institute of Child Health and Human Develop-
ment–National Institutes of Health (P30HD03110). We thank Megumi Aita for performing in situ hybridization and
Brittany Wright for help with perfusion of mice.
The authors declare no competing financial interests.
Correspondence should be addressed to Mark J. Zylka, Department of Cell Biology and Physiology, UNC Neuro-
science Center, University of North Carolina, CB #7545, Chapel Hill, NC 27599. E-mail: zylka@med.unc.edu.
DOI:10.1523/JNEUROSCI.0133-13.2013
Copyright © 2013 the authors 0270-6474/13/3311314-09$15.00/0
11314 • The Journal of Neuroscience, July 3, 2013 • 33(27):11314 –11322
deficient mice and humans. This accumulation impairs bone
mineralization and causes a rare, painful, and sometimes fatal
disease called hypophosphatasia (Millán, 2006a; Mornet, 2007;
Whyte et al., 2012).
TNAP is also widely expressed in the brain and developing
spinal cord (Narisawa et al., 1994; MacGregor et al., 1995; Fonta
et al., 2004; Langer et al., 2008), suggesting a role for this enzyme
in the CNS. Indeed, Tnap /  (also referred to as Alpl / ) mice
develop seizures by 2 weeks of age and then die 1–2 d later
(Waymire et al., 1995; Narisawa et al., 1997). Children presenting
with the most severe cases of hypophosphatasia may also mani-
fest seizures caused by the affected metabolism of vitamin B6
(Millán, 2006b; Mornet, 2007; Whyte et al., 2012).
TNAP also hydrolyzes extracellular ATP to promote the ax-
onal growth of hippocampal neurons (Díez-Zaera et al., 2011)
and TNAP can redundantly serve as a source of extracellular
adenosine in the hippocampus when NT5E is deleted (Zhang et
al., 2012). TNAP can thus regulate neuronal functions by metab-
olizing nucleotides. Here, we unexpectedly discovered a triple
redundant role for TNAP, PAP, and NT5E in rapidly generating
adenosine and inhibiting excitatory neurotransmission between
primary somatosensory neurons and spinal neurons. Our present
study, combined with our previous work (referenced above),
firmly establishes that TNAP, PAP, and NT5E metabolize extra-
cellular nucleotides in the somatosensory system.
Materials and Methods
Animals. All procedures involving vertebrate animals were approved by
the institutional animal care and use committee at the University of
North Carolina at Chapel Hill. Mice were raised under a 12:12 light:dark
cycle and used during the light phase. C57BL/6 mice were purchased
from The Jackson Laboratory or bred inhouse from C57BL/6J stock.
Pap  / , Nt5e  / , and A1R
 /  mice were backcrossed to C57BL/6J
mice for 10 generations (Thompson et al., 2004; Vihko et al., 2005; Wu
et al., 2005; Zylka et al., 2008). Tnap  /  mice were maintained on a
12.5% C57BL/6/87.5% 129J background (Narisawa et al., 1997; Yadav et
al., 2012). dKO mice were generated by breeding backcrossed Nt5e  / 
and Pap  /  mice.
Enzyme histochemistry. Tissue was dissected from adult male mice
(6 –12 weeks old) and immersion fixed in 4% paraformaldehyde, 0.1%
phosphate buffer, pH 7.4, at 4°C. Tissue was then cryoprotected in 30%
sucrose, 0.1 M phosphate buffer, pH 7.3, at 4°C for at least 24 h. DRG and
spinal cord were sectioned (20 and 30 m thick, respectively) on a cryo-
stat and collected on Superfrost Plus slides (DRG) or as free-floating
sections (spinal cord). Because Tnap  /  mice die shortly (2 weeks)
after birth (Narisawa et al., 1997), AMP histochemistry was performed
with 11 d-old wild-type (WT) and Tnap  /  mice (littermates). These
young mice were perfused with 4% paraformaldehyde, 0.1% phosphate
buffer, pH 7.4, and then the entire spinal column was then dissected,
cryoprotected, and sectioned (24 m thick) on a cryostat and collected
on Superfrost Plus slides.
For alkaline phosphatase histochemistry, lumbar DRG and spinal cord
sections were incubated in a substrate solution containing 1 l/ml ni-
troblue tetrazolium (NBT; 37.5 mg/ml in 50% dimethylformamide;
Fisher Scientific) and 1 l/ml 5-bromo-4-chloro-3-indolyl phosphate,
4-toluidine salt (BCIP; 50 mg/ml in 100% dimethylformamide; Roche)
in 100 mM Tris, pH 8.5, 50 mM MgCl2, 100 mM NaCl, and 0.1% Tween
20  5 mM levamisole. DRG sections were incubated for 90 min; spinal
cord sections were incubated from 40 min to 2 h.
AMP histochemistry was performed as described previously (Zylka et
al., 2008). Briefly, 1 mM AMP (DRG and HEK293 cells) and 3 mM AMP
(spinal cord) were used as substrate in Tris-maleate buffer containing 20
mM MgCl2, pH 7.0 or 8.5, with 2.4 mM lead nitrate. Where indicated, we
included 5 mM levamisole or 20 mM L-tartrate and 10 M -me-ADP for
rinse and incubation steps. Quantification of staining intensity was per-
formed using ImageJ. A rectangle was drawn over lamina II or a subset of
DRG neurons and the mean gray scale (a measure of pixel intensity) was
calculated from 6 to 10 images from each genotype and averaged. To
make the numbers more intuitive to the reader, we took the inverse of the
mean gray scale and multiplied by 1000 so that larger numbers corre-
sponded to darker staining, as described previously (Street et al., 2011).
In situ hybridization. We generated a plasmid for sense and antisense
riboprobe synthesis by digesting a mouse TNAP I.M.A.G.E clone
(6807509) with EcoRI and BamHI, and then subcloned the resulting
1190 bp fragment into pBS-KS(). In situ hybridization with
digoxigenin-labeled riboprobes (1 g/ml) was performed as described
previously (Dong et al., 2001). Sections were mounted in aqueous
mounting medium (DAKO). Images were acquired with a Zeiss Axios-
kop and Olympus DP-71 camera.
Cell culture. HEK293 cells were grown on polylysine-coated glass-
bottom culture dishes (P35G-0 –10-C; MatTek) or on coverslips in
DMEM containing 10% fetal bovine serum, 100 units/ml penicillin, and
100 g/ml streptomycin. Cells were transfected with Lipofectamine Plus
(Invitrogen) in DMEM containing 1% fetal bovine serum, which was
replaced with fresh growth medium after 4 h. The total amount of DNA
per transfection was adjusted to 1 g by adding pcDNA3.1(); 100 ng of
pCS-Venus was also included to identify transfected cells. A full-length
mouse TNAP expression construct was generated by digesting I.M.A.G.E
clone 6807509 with EcoRI and NotI and then subcloning this fragment
into pcDNA3.1 using the same restriction sites. This construct was used
for histochemical and calcium imaging experiments. Cells were fixed
24 h after transfection.
Calcium imaging. Calcium imaging experiments using the human A2B
adenosine receptor and chimeric Gqs plasmids were performed as described
previously (Rittiner et al., 2012). Twenty-four hours after transfection,
HEK293 cells were washed and loaded with 2 M Fura-2 AM (F1221; Invit-
rogen) and 0.02% Pluronic F-127 (P3000-MP; Invitrogen) in assay buffer.
Cells were then washed three times in assay buffer and incubated for 30 min
before imaging on a Nikon Eclipse Ti microscope. A Sutter DG-4 light source
(excitation 340 nm/380 nm; emission 510 nm) and Andor Clara CCD cam-
era were used to image calcium responses. After 40 s of baseline imaging,
assay buffer was removed by gentle aspiration and replaced with assay buffer
containing agonist (adenosine or AMP). Area under the curve values were
calculated using the 60 s time period after agonist addition relative to baseline
fluorescence ratio on a cell-by-cell basis and then averaged over all cells for a
given condition.
Slice preparation. Transverse (800 –900 m, used in field recordings)
and sagittal (400 m, used in FSCV experiments) slices were prepared as
described previously (Street et al., 2011). Briefly, spinal cords from 1- to
2-month-old mice were dissected and sectioned on a Vibratome 3000EP
at 4° in buffer containing the following in mM: 87 NaCl, 2.5 KCl, 1.25
NaH2PO4, 26 NaHCO3, 75 sucrose, 10 glucose, 1.5 ascorbic acid, 0.5
CaCl2, and 7 MgCl2. The slices were then incubated for 45 min at 37°C
and then at room temperature in artificial CSF containing the following
(in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 25 glucose, 2.5
CaCl2, 1.5 MgCl2. All solutions were bubbled with 95% O2/5% CO2 for
the duration of the dissection and incubation steps.
FSCV. FSCV experiments were performed as described previously
(Street et al., 2011). Briefly, disk-shaped carbon-fiber microelectrodes
were placed in sagittal mouse spinal cord slices. The electrode’s potential
was held at 0.4 V between scans and was ramped from 0.4 V to 1.5 V
at a scan rate of 400 V/s every 100 ms. The peak at 1.0 V was used to
quantify adenosine concentration. FSCV data were collected with a cus-
tom LABVIEW program, Tar Heel CV, and were viewed in the form of
color plots with sequentially stacked cyclic voltammograms shown over
time (abscissa) that were plotted against the electrode potential displaced
on the ordinate where the switching potential (1.5 V) was in the middle.
Current was displayed in false color, with oxidative currents being shown
in green and reductive currents being shown in blue and black. These
current traces were converted to concentration from calibrations per-
formed in a flow injection apparatus in which adenosine (1–10 M) was
introduced to the electrode surface.
To measure adenosine production in lamina II, AMP was pressure
ejected 5 times at 5 min intervals with a Picospritzer III (Parker Instru-
mentation) for 1 s at 20 psi from a micropipette inserted into the tissue
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100 m away from the carbon-fiber micro-
electrode. AMP (09130; Fluka) was freshly pre-
pared before each experiment.
Field potential recordings. Transverse spinal
cord slices containing one dorsal root were
placed in the recording chamber and field po-
tential recordings were performed as described
previously (Street et al., 2011). Briefly, a boro-
silicate glass recording electrode with a tip re-
sistance of 1–2 M was placed in lamina II to
record field potentials evoked by dorsal root
stimulation. The dorsal root was stimulated
with a suction electrode for 0.5 ms at 5 times
the intensity needed to evoke a maximal re-
sponse. The root was stimulated once every
10 s (0.1 Hz) and every 6 signals were averaged
to give a single point for every minute of re-
cording. The resulting signals were filtered at 1
kHz, amplified 1000 times with a Multiclamp
700B amplifier, captured at 10 kHz with an
Axon Digidata 1440A, and analyzed using
pClamp 10 software (Molecular Devices).
AMP (250 M) was bath applied after 5 min of
baseline recording, washed off for 5 min, and
then adenosine (250 M) was bath applied to
confirm that the A potential was sensitive to
adenosine. One experiment was performed per
slice.
Quantitative RT-PCR. Total RNA was pre-
pared from DRG of adult mice using TRIzol
reagent (Invitrogen). First-strand cDNA was
synthesized using the Superscript III reverse
transcriptase kit (Invitrogen). Quantitative
RT-PCR was performed with SYBR Green
detection (Invitrogen Invitrogen) using a
Rotorgene 3000 thermal cycler (Corbett Re-
search) and Rotorgene software (version 6.0). Expression of Tnap
(Alpl ) was quantified with primers spanning the ninth intron (5CT-
GACTGACCCTTCGCTCTC3, 5TCATGATGTCCGTGGTCAAT3) us-
ing kidney cDNA as a positive control. Tnap expression was normalized to
levels of Actb for each sample (primers spanned the first intron of Actb: 5CA-
GCTTCTTTGCAGCTCCTT3, 5CACGATGGAGGGGAATACAG3).
Statistical tests. Statistical analysis was performed using Microsoft Ex-
cel and GraphPad Prism software. All data are shown as means  SE.
Results
TNAP is widely expressed in DRG neurons and spinal
cord neurons
Using a quantitative electrochemical technique (FSCV), we pre-
viously found that genetic deletion of PAP and NT5E using dKO
mice reduced, but did not eliminate, hydrolysis of AMP to aden-
osine in dorsal spinal cord at physiological (neutral) pH (Street et
al., 2011). In contrast, essentially no adenosine was generated in
dKO mice at pH 5.6. These data collectively suggested that at least
one additional AMP hydrolytic enzyme was present and that this
enzyme was active at neutral but not acidic pH. Alkaline phos-
phatases can dephosphorylate ATP, ADP, and AMP (Zimmer-
mann, 2006b; Ciancaglini et al., 2010), leading us to hypothesize that
an alkaline phosphatase might generate adenosine in adult spinal
cord.
To determine whether an alkaline phosphatase was present in
DRG and spinal cord, we performed NBT/BCIP histochemistry
at an alkaline pH, pH 8.5, with tissues from WT, Pap / ,
Nt5e / , and dKO adult mice (n  3 for each genotype). We
found that BCIP was hydrolyzed in virtually all DRG neurons
(Fig. 1A–D) and throughout the spinal cord gray matter (Fig.
2A–D) in all four genotypes. The nonselective alkaline phospha-
tase inhibitor levamisole abolished staining in DRG from all four
genotypes (Fig. 1E–H) and in spinal cord from Pap / and dKO
mice (Fig. 2F,H), indicating that an alkaline phosphatase was in-
deed present in these tissues. Levamisole did not inhibit NBT/BCIP
histochemical staining in lamina II of WT or Nt5e / mice (Fig.
2E,G). This residual staining clearly originated from PAP, because
staining was abolished in Pap / and dKO mice (Fig. 2F,H). Al-
though PAP is classified as an “acid phosphatase,” we found that
PAP could hydrolyze a commonly used substrate of alkaline phos-
phatases, BCIP. Further, our data indicate that PAP is also active at
alkaline pH values, as was shown previously (Van Etten, 1982).
In the mouse, there are four genes that encode functional
alkaline phosphatase enzymes (Millán, 2006b); of these, TNAP
was previously found to be expressed in embryonic spinal cord
(Narisawa et al., 1994; MacGregor et al., 1995). To determine
whether TNAP was expressed in adult DRG and spinal cord, we
performed in situ hybridization with TNAP-specific riboprobes.
We found that antisense riboprobes against TNAP labeled all
DRG neurons and neurons throughout spinal cord gray matter
(Fig. 3A,C). In contrast, the sense (control) probes against TNAP
only showed background staining (Fig. 3B,D). These data indi-
cate that TNAP is expressed broadly in primary sensory neurons
and spinal neurons. Given that TNAP is expressed and active (see
below) in most if not all DRG neurons, TNAP is likely present in
all sensory neuron subtypes.
TNAP rapidly hydrolyzes extracellular AMP to adenosine in
live cells
TNAP can dephosphorylate a broad spectrum of substrates, includ-
ing nucleotides such as ATP, ADP, and AMP (Zimmermann, 2006b;
Ciancaglini et al., 2010). To determine whether TNAP can dephos-
Figure 1. Alkaline phosphatase activity is present in DRG neurons. A–H, Lumbar DRG sections from adult WT, Pap  / ,
Nt5e  / , and dKO mice were stained using BCIP histochemistry at pH 8.5 in the absence (A–D) or presence (E–H ) of levamisole
(Lev, 5 mM; n  3 for each genotype). Scale bar, 50 m.
Figure 2. Alkaline phosphatase activity is present throughout the adult spinal cord. A–H, Lumbar spinal cord sections from WT,
Pap  / , Nt5e  / , and dKO mice were stained using BCIP histochemistry at pH 8.5 in the absence (A–D) or presence (E–H ) of
levamisole (5 mM; n  3 for each genotype). Scale bar, 200 m.
11316 • J. Neurosci., July 3, 2013 • 33(27):11314 –11322 Street et al. • TNAP Redundantly Generates Adenosine
phorylate AMP in a cellular context, we transfected HEK293 cells
with a mouse TNAP expression construct and then performed AMP
histochemistry. We found that TNAP-transfected cells were in-
tensely stained when AMP was used as substrate at pH 8.5, whereas
HEK293 cells transfected with empty vector were unstained (Fig.
4A,B). These data indicate that TNAP can dephosphorylate AMP
when expressed in cells.
To determine whether TNAP can hydrolyze AMP and activate
adenosine receptors in live cells, we used a cell-based assay that
links the Gs-coupled A2B adenosine receptor (A2BR) to phospho-
lipase C and calcium mobilization (Rittiner et al., 2012). Adeno-
sine rapidly activates A2BR in this assay, whereas AMP does not
activate A2BR directly (AMP only activates A2BR if cells are also
cotransfected with an AMP ectonucleotidase; Rittiner et al.,
2012). Therefore, we transfected HEK293 cells with a chimeric
G-protein (Gqs), human A2BR, and TNAP and then stimulated
these cells with either adenosine or AMP (each at 1 mM). We
found that adenosine and AMP both induced a rapid onset cal-
cium response in TNAP-transfected cells (Fig. 4C,D; cotrans-
fected cells were identified using a Venus expression plasmid,
data not shown). AMP did not evoke a calcium response in cells
lacking A2BR (no receptor controls that were transfected with Gqs
and TNAP; Fig. 4C,D).
In addition, the TNAP-specific inhibitor MLS-0038949 (Dahl
et al., 2009; Sergienko et al., 2009) blocked the rapid onset cal-
cium response to AMP but not to adenosine in TNAP-transfected
cells (Fig. 4E,F). These data indicate that TNAP can rapidly hy-
drolyze extracellular AMP and activate adenosine receptors in
live cells. MLS-0038949 did not alter calcium responses to aden-
osine, thus ruling out the possibility that MLS-0038949 blocks
A2BR, interferes with steps downstream of receptor signaling, or
compromises cell health.
TNAP, PAP, and NT5E account for nearly all of the AMP
ectonucleotidase activity in DRG and spinal cord
Next, we performed AMP histochemistry in the absence or pres-
ence of MLS-0038949 to determine whether TNAP participated
in hydrolyzing AMP in adult DRG and spinal cord. Relative to
WT mice, AMP histochemical staining was reduced in DRG sec-
tions from dKO mice at pH 7.0 and 8.5, although pronounced
membrane staining remained at both pH values (Fig.
5 A, B, E, F ). This membrane staining was eliminated when sec-
tions were incubated with the TNAP inhibitor MLS-0038949
(Fig. 5C, D, G,H ), revealing that this staining originated from
TNAP activity.
In addition, AMP histochemical staining was greatly reduced
in spinal cord sections from dKO mice at pH 7.0 (relative to WT
mice), as we found previously (Street et al., 2011), and at pH 8.5
(Fig. 6A,B,E,F). At pH 8.5, weak AMP histochemical staining
was still present in a broad region of the dorsal horn and on blood
vessels of dKO mice (Fig. 6F). This residual staining was elimi-
nated in the presence of MLS-0038949 (Fig. 6H), indicating that
it originated from TNAP activity. We obtained similar AMP his-
tochemical results with WT and dKO slices in the presence and
absence of the nonselective alkaline phosphatase inhibitor le-
vamisole (5 mM; data not shown). These experiments indicate
that TNAP, PAP, and NT5E account for most if not all
extracellular/membrane-delimited AMP hydrolytic activity in
DRG and spinal cord.
We were unable to use adult Tnap /  mice for experiments
because these mice die shortly after birth (Waymire et al., 1995;
Narisawa et al., 1997). Instead, we resorted to using early postna-
tal Tnap /  mice. To confirm that genetic deletion of Tnap was
equivalent to pharmacological inhibition of TNAP, we per-
formed AMP histochemistry with DRG and spinal cord tissue
from young (11-d-old) WT and Tnap /  mice at pH 8.5 (Fig. 7).
Figure 3. TNAP is expressed in DRG and spinal cord neurons. In situ hybridization of adult
mouse lumbar DRG (A,B) and spinal cord (C,D) with antisense (A,C) and sense (B,D) TNAP
riboprobes. Scale bars: B, 75 m; D, 250 m.
Figure 4. TNAP rapidly hydrolyzes extracellular AMP to adenosine in a cell-based assay and
is inhibited by MLS-0038949. A, B, HEK293 cells transiently transfected with mouse TNAP (A) or
empty expression vector (B) were stained using AMP histochemistry. The AMP concentration
was 3 mM. Scale bar, 50 m. C–F, Calcium mobilization and area under the curve (AUC) mea-
surements in HEK293 cells expressing mouse TNAP, Gqs, and either human A2BR or no receptor
(NR). Cells were stimulated with adenosine (ADO, 1 mM, black) or AMP (1 mM) in the absence
(C,D) or presence (E,F ) of the TNAP inhibitor MLS-0038949 (50 M; added 40 s before stimu-
lation and during stimulation). AUC measurements extended 1 min from agonist addition.
Paired t tests were used to compare the AUC data. Asterisks indicate a statistically significant
difference when compared with ADO condition (***p 	 0.0005). All data are the average of
two experiments performed in duplicate (n  20 –58 cells per condition).
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We found that AMP histochemical staining was greatly reduced
throughout Tnap /  DRG compared with DRG from WT litter-
mates (Fig. 7A,B), further demonstrating that TNAP was present
and capable of hydrolyzing AMP in virtually all DRG neurons.
Likewise, AMP histochemical staining that was present through-
out the spinal cord gray matter of WT mice (Fig. 7C) was elimi-
nated in Tnap /  spinal cord with the exception of the dorsal
horn (Fig. 7D; analogous to what we observed when TNAP was
pharmacologically inhibited, as shown in Fig. 6G). This residual
AMP histochemical activity in Tnap /  dorsal horn was elimi-
nated when sections were incubated with L-tartrate, an inhibitor
of PAP, and -methylene ADP (-me-ADP), an inhibitor of
NT5E (Fig. 7E,F; analogous to what we observed when Pap and
Nt5e were genetically eliminated, as shown in Fig. 6F,H). There-
fore, using two independent methods to inhibit TNAP (one ge-
netic and one pharmacological), we found that TNAP, PAP, and
NT5E redundantly hydrolyzed AMP in DRG neurons and dorsal
spinal cord.
We recently used FSCV to quantify adenosine concentration
with subsecond resolution in the spinal microdomain (lamina II)
where PAP and NT5E are located (Street et al., 2011). FSCV can
be used to detect adenosine based on a 1.0 V oxidation peak that
is specific to adenosine but not nucleotides (Swamy and Venton,
2007). In our previous study, we found that peak adenosine pro-
duction (after pressure ejection of 100 M AMP into lamina II)
was reduced by 50% in spinal cord slices from dKO mice, to
1.5 M adenosine (Street et al., 2011). This concentration is
similar to the EC50 of adenosine at A1R (1.4 M; Rittiner et al.,
2012) and therefore should be sufficient to activate A1R even
though PAP and NT5E were genetically deleted.
To determine whether TNAP generates adenosine in lamina
II, we used FSCV to quantify adenosine production in spinal cord
slices from WT and dKO mice (MLS-0038949). We found that
adenosine production was reduced by 50% when 100 M AMP
was pressure ejected onto lamina II of dKO mice (Fig. 8A,B,E,F),
replicating our previous finding (Street et al., 2011). Inhibition of
TNAP in WT slices (by adding MLS-0038949 to the bath) did not
reduce adenosine production (Fig. 8C,E,F), analogous to our
previous results showing that deletion of PAP alone did not re-
duce adenosine generation at neutral pH (Street et al., 2011).
However, the addition of MLS-0038949 to the bath significantly
reduced peak and sustained adenosine production in dKO slices
to 	1 M (Fig. 8D–F), highlighting that simultaneous inhibition
of TNAP, PAP, and NT5E is required to reduce adenosine pro-
duction to near baseline levels in spinal lamina II. Moreover,
these experiments revealed that TNAP, PAP, and NT5E redun-
Figure 5. MLS-0038949 inhibits AMP hydrolytic activity in DRG from WT and dKO adult mice.
DRG sections from WT (A,C,E,G) and dKO (B,D,F,H ) mice were stained using AMP histochemis-
try at pH 7.0 (A–D) or pH 8.5 (E–H ) in the absence or presence of MLS-0038949 (50 M). AMP
concentration was 1 mM. Similar results were obtained from n  3 mice from each genotype.
Scale bar, 50 m. Staining intensity was quantified as described in the Materials and Methods
and reported (upper right) as mean  SEM. Repeated measures one-way ANOVA and Bonfer-
roni’s post hoc tests were used to compare staining intensity between genotypes. The only
significant decrease in staining intensity at pH 7.0 was found when comparing WT tissue with
dKO tissue in the presence of MLS-0038949 ( p 	 0.0005). At pH 8.5, sections from dKO mice in
the presence of MLS-00038949 showed significantly less staining ( p 	 0.005) than sections
from WT mice  MLS-0038949.
Figure 6. MLS-0038949 inhibits AMP hydrolytic activity in spinal cord from WT and dKO
adult mice. Spinal cord sections from WT (A,C,E,G) and dKO (B,D,F,H ) mice were stained using
AMP histochemistry at pH 7.0 (A–D) or pH 8.5 (E–H ) in the absence or presence of MLS-
0038949 (50 M). The AMP concentration was 3 mM. Similar results were obtained from n  3
mice from each genotype. Scale bar, 200 M. Staining intensity was quantified as described in
the Materials and Methods and is reported (bottom left) as mean  SEM. Repeated-measures
one-way ANOVA and Bonferroni’s post hoc tests were used to compare staining intensity be-
tween genotypes. Slices from dKO mice (pH 7.0 and 8.5) in the presence of MLS-00038949
showed significantly less staining ( p 	 0.0005) than in tissue from WT mice (pH 7.0 and 8.5) in
the presence or absence of MLS-00038949. There were no statistically significant decreases in
staining intensity when comparing tissue from dKO mice in the presence or absence of MLS-
00038949 at pH 7.0 and 8.5.
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dantly and rapidly generate most if not all adenosine from extra-
cellular AMP in dorsal spinal cord.
AMP inhibits excitatory neurotransmission in spinal cord,
but does not inhibit neurotransmission when TNAP, PAP,
and NT5E are inhibited simultaneously
Adenosine inhibits synaptic transmission in the dorsal spinal
cord by activating A1R on primary somatosensory afferents (pre-
synaptically) and on spinal neurons (postsynaptically; Li and
Perl, 1994; Lao et al., 2001). In addition, AMP has long been
known to inhibit neurons in the dorsal spinal cord (Salter and
Henry, 1985), although whether this reflects direct activation of
adenosine receptors by AMP (Rittiner et al., 2012) or indirect
activation via ectonucleotidases that hydrolyze AMP to adeno-
sine is unknown. Given that we could now inhibit the three main
AMP ectonucleotidases that are present in dorsal spinal cord, we
next sought to resolve this longstanding issue while also assessing
the extent to which TNAP regulates spinal neurotransmission by
generating adenosine. To accomplish these goals, we assessed
how AMP and adenosine (each bath applied at 250 M) affected
field EPSPs (fEPSPs) in spinal cord slices when zero, one, two, or
all three AMP ectonucleotidases were inactivated.
First, we found that AMP and adenosine reduced fEPSP am-
plitude in lamina II of WT slices by 50% (Fig. 9Aa,Ab,B), high-
lighting that AMP and adenosine were equally effective at
reducing excitatory neurotransmission. This inhibitory effect on
neurotransmission was entirely dependent on A1R activation, be-
cause AMP and adenosine did not inhibit fEPSP amplitude in
slices from A1R
 /  mice (Fig. 9B).
To determine whether this inhibitory effect of AMP required
PAP and/or NT5E, we quantified fEPSP amplitude in response to
AMP and adenosine in spinal cord slices from WT, Pap / ,
Nt5e / , and dKO mice. We found that AMP and adenosine
were equally effective at inhibiting fEPSPs in all of these geno-
types (Fig. 9C), suggesting that a third AMP hydrolytic enzyme
was active in this physiological preparation.
To determine whether TNAP was this third ectonucleotidase,
we quantified fEPSP amplitude in WT, Pap / , Nt5e / , and
dKO slices that were incubated with the TNAP-specific inhibitor
MLS-0038949. We found that AMP and adenosine were equally
effective at inhibiting fEPSPs in slices from WT mice and Pap / 
mice that were incubated with MLS-0038949 (Fig. 9D,E). In con-
trast, AMP was significantly less effective at inhibiting fEPSPs in
Nt5e /  slices in the presence of MLS-0038949, although the
inhibitory effect of AMP was not eliminated (Fig. 9D; AMP still
significantly reduced fEPSP amplitude relative to baseline). Re-
markably, the inhibitory effect of AMP was lost only when all
three ectonucleotidases (TNAP, PAP, and NT5E) were inhibited
Figure 7. AMP histochemistry in DRG and spinal cord from Tnap  /  mice. DRG (A,B) and
spinal cord (C–F ) sections from WT (A,C,E) and Tnap  /  (B,D,F ) mice were stained using
AMP histochemistry at pH 8.5. The AMP concentration was 3 mM. E, F, AMP histochemistry at pH
8.5 in the presence of L-tartrate (20 mM) to inhibit PAP and -me-ADP (10 M) to inhibit
NT5E. Tissue was obtained from 11-d-old mice (WT, n  3; Tnap  / , n  3).
Figure 8. Triple inhibition of TNAP, PAP, and NT5E virtually eliminates hydrolysis of AMP to
adenosine in spinal lamina II. FSCV was used to measure adenosine production at subsecond
resolution. A–D, FSCV color plots: 100 M AMP was pressure ejected for 1 s onto lamina II of WT
(A,C) or dKO (B,D) mice in the absence or presence of MLS-0038949 (50 M). E, Adenosine
concentration calculated from 1.0 V current (dashed horizontal lines in A–D). Inset: Cyclic vol-
tammogram confirms that adenosine was produced (plotted from dashed vertical line in A). F,
Peak adenosine concentration after pressure ejecting AMP onto lamina II (n  5 slices for each
condition). t tests were used for comparisons. **p 	 0.005.
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(Fig. 9E; adenosine remained effective un-
der all conditions). These data strongly
suggest that all three enzymes are capable
of hydrolyzing AMP to adenosine and fa-
cilitate inhibition of excitatory neu-
rotransmission through A1R activation.
With our unprecedented genetic and
pharmacological control over these en-
zymes, we were able to show that TNAP,
PAP, and NT5E are triply redundant in
the dorsal spinal cord. In addition, our
data strongly support the indirect
(ectonucleotidase-dependent) model in
which the biological effects of extracellu-
lar AMP are mediated via hydrolysis to
adenosine. Indeed, adenosine concentra-
tion fell below the EC50 of A1R only when
all three enzymes were deleted/inhibited
(Fig. 8F).
Last, to determine whether Tnap ex-
pression in DRG changed when Pap
and/or Nt5e were deleted, we measured
Tnap mRNA levels in WT, Pap / ,
Nt5e / , and dKO mice using quantita-
tive RT-PCR. We found that Tnap mRNA
levels did not change relative to WT in any
of the knock-out lines (Fig. 9F), ruling out
the possibility that Tnap expression com-
pensated for the loss/deletion of other
AMP ectonucleotidases.
Discussion
Nucleotides and nucleosides play key roles
in pain signaling and sensory biology. ATP,
acting through purinergic receptors, can
sensitize DRG neurons and cause long-
lasting thermal hyperalgesia and mechani-
cal allodynia (Nakagawa et al., 2007; Sowa et
al., 2010c) and adenosine has antinocicep-
tive effects (Sawynok, 2007; Zylka, 2011).
We previously identified PAP and NT5E as
two ectonucleotidases that generate extra-
cellular adenosine from AMP and found
that both enzymes play important roles in
nociceptive physiology (Zylka et al., 2008; Sowa et al., 2010a). Al-
though AMP hydrolysis was reduced when each of these enzymes
was deleted alone or in combination, we were surprised that AMP
hydrolytic activity was not eliminated, suggesting the existence of at
least one more AMP ectonucleotidase in DRG neurons and/or
dorsal spinal cord (Street et al., 2011).
In our present study, we found that TNAP is widely expressed
in DRG neurons and spinal cord and can dephosphorylate AMP
in these tissues. These findings were based on our use of three
different assays: enzyme histochemistry, quantitative FSCV, and
slice electrophysiology. Although TNAP, PAP, and NT5E col-
lectively account for most if not all AMP ectonucleotidase activity
in sensory circuits, we cannot formally exclude the possibility
that an additional AMP ectonucleotidase is present, particularly
because a small amount of adenosine was generated in FSCV
experiments when TNAP, PAP, and NT5E were all inhibited (Fig.
8F). However, the concentration of this residual adenosine was
below the EC50 for A1R activation and was not sufficient to inhibit
neurotransmission (Fig. 9E), suggesting that this residual adeno-
sine had no discernible impact on neuronal physiology. Because
this residual adenosine was first detected several seconds after
pressure ejecting AMP instead of immediately afterward, the re-
sidual adenosine is likely of enzymatic origin rather than being
present in the AMP stock solution. One possibility is that this
residual adenosine originates from TNAP (e.g., if MLS-0038949
did not fully penetrate into the slice preparation and fully inhibit
TNAP or if MLS-0038949 reversibly interacts with TNAP—in-
deed, MLS-0038949 is an uncompetitive inhibitor of TNAP
[Kiffer-Moreira et al., 2013] and its binding is reversible).
Our research now resolves a longstanding (40 years) ques-
tion in the somatosensory field: what are the molecular identities
of the enzymes that hydrolyze extracellular AMP to adenosine in
dorsal spinal cord? (Fieschi and Soriani, 1959; Scott, 1967). Our
experiments indicate that TNAP, PAP, and NT5E are each capa-
ble of hydrolyzing AMP to adenosine in spinal lamina II and that
each enzyme inhibits spinal circuit excitability by generating
adenosine and activating A1R. Note that PAP and NT5E are lo-
calized to lamina II, whereas TNAP is more broadly distributed in
Figure 9. AMP inhibits excitatory neurotransmission in lamina II of WT, Pap  / , Nt5e  / , and dKO mice but not after triple
inhibition of TNAP, PAP, and NT5E. A, Representative A fEPSPs in lamina II of WT spinal cord slices before (solid line) and after
(dashed line) the addition of 250 M AMP (Aa) or 250 M adenosine (ADO; Ab) to perfusate. B, Normalized fEPSP amplitude in WT
and A1R
 /  spinal cord slices (n  25 and 11, respectively). t tests were used to compare fEPSP amplitude in WT and A1R
 / 
slices at each time point. ***p 	 0.0005. C, Normalized fEPSP amplitude in WT, Pap  / , Nt5e  / , and dKO spinal cord slices.
(n  25, 10, 20, and 16, respectively). No significant differences were found between genotypes using one-way ANOVA followed
by Bonferonni’s post hoc test). D, Normalized fEPSP amplitude in WT, Pap  / , and Nt5e  /  slices incubated with TNAP
inhibitor MLS-0038949 (50 M; n  11 for all genotypes). There was a significant reduction in the inhibitory effect of AMP on slices
from Nt5e  /  mice compared with WT and Pap  /  mice (all incubated with MLS-0038949; p 	 0.005, one-way ANOVA,
followed by a Bonferroni post hoc test.) E, Normalized fEPSP amplitude in WT and dKO mice incubated with MLS-0038949 (n  9
and 12, respectively). t tests were used to compare WT with dKO responses at each time point. ***p 	 0.0005. F, Genetic deletion
of Pap and/or Nt5e does not change the expression of Tnap mRNA. Tnap expression levels were measured in DRG from Pap  / ,
Nt5e  / , and dKO mice by quantitative RT-PCR. Results are given as arbitrary units, normalized to expression of -actin. No
significant differences were observed between genotypes (one-way ANOVA   0.05, p  0.77, n  3 for each genotype).
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the dorsal horn and throughout spinal cord, consistent with
TNAP being found in nociceptive and nonnociceptive regions of
spinal cord. Our results support a major role for TNAP, PAP, and
NT5E in regulating extracellular adenosine concentration, extra-
cellular nucleotide metabolism, and neurophysiology in primary
somatosensory neurons and spinal cord.
Intriguingly, the somatosensory system is not the only loca-
tion where TNAP functions redundantly. Indeed, TNAP is often
coexpressed with other ectonucleotidases (Zimmermann, 2006a;
Langer et al., 2008) and redundantly generates adenosine from
extracellular AMP in the hippocampus, including when Nt5e is
deleted (Zhang et al., 2012). The importance of TNAP in gener-
ating adenosine in the nervous system has been underappreci-
ated, but clearly should be considered in future studies and when
interpreting previous studies that did not control for TNAP ac-
tivity (Dunwiddie et al., 1997; Klyuch et al., 2012; Lovatt et al.,
2012). This is particularly important when using physiological
readouts because inhibition of TNAP alone, PAP alone, NT5E
alone, or any pairwise combination (TNAP and PAP; TNAP and
NT5E; PAP and NT5E) was not sufficient to block AMP hydro-
lysis to adenosine or to block maximal inhibition of neurotrans-
mission by a nucleotide (Fig. 9C; Zhang et al., 2012). We can only
speculate as to why the nervous system contains redundant en-
zymes that generate adenosine. Such redundancy could reflect
the fact that there are activity-dependent changes in extracellular
pH, including in the spinal dorsal horn (Syková and Svoboda,
1990), that necessitate multiple enzymes for efficient extracellu-
lar nucleotide metabolism and recycling.
Previously, we found that thermal and mechanical sensitivity
was enhanced in models of chronic pain when PAP or NT5E were
deleted alone or in combination (Zylka et al., 2008; Sowa et al.,
2010a). Tnap /  mice die shortly after birth (Waymire et al.,
1995; Narisawa et al., 1997), making it impossible for us to assess
how TNAP deletion affects nociceptive behaviors in adults.
Moreover, lumbar nerve roots are smaller in Tnap /  neonates
(Narisawa et al., 1997), suggesting that TNAP is required for
somatosensory circuit development or maintenance. Experi-
ments with Tnap conditional knock-out mice could be equally
challenging, because it will likely be necessary to delete TNAP in
adult DRG neurons and the spinal cord (i.e., to delete TNAP from
somatosensory afferents and spinal neurons that are postsynaptic
to somatosensory afferents).
We recently found that adenosine and AMP can activate A1R
directly in cell lines and in neurons (Rittiner et al., 2012). How-
ever, our current data indicate that AMP does not inhibit neu-
rotransmission via direct activation of A1R (as evidenced by the
fact that AMP did not inhibit neurotransmission when all three
ectonucleotidases were inhibited/deleted). This discrepancy im-
mediately raises the question as to why AMP did not inhibit
neurotransmission via direct effects on A1R when AMP (and a
nonhydrolyzable AMP analog) activated A1R directly (indepen-
dent of ectonucleotidase activity) in cell lines. Although we do
not have a definitive explanation for this discrepancy, we specu-
late that this is due to functional selectivity of A1R ligands (Verzijl
and Ijzerman, 2011). Functional selectivity refers to the ability of
ligands to preferentially activate a subset of signal transduction
pathways that are downstream of a given receptor.
A1R is classically considered to be a Gi/Go-coupled receptor
and to inhibit adenylate cyclase. In our previous study, we exclu-
sively monitored Gi-coupled signaling in cells to demonstrate
that AMP can activate A1R directly (Rittiner et al., 2012). How-
ever, A1R also couples to other downstream mediators, including
-arrestin (and downstream kinases) and phospholipase C (via
G subunits; Verzijl and Ijzerman, 2011). It is increasingly clear
that A1R displays functional selectivity. A 5-modified adenosine
analog (LUF5589) was shown to preferentially activate the Gi
pathway downstream of A1R, whereas the parent compound
lacking the 5 modification (MRS542) activated both the Gi and
-arrestin pathways (Langemeijer et al., 2013). Likewise, a differ-
ent 5-modified agonist (CPeCA) preferentially activated the Gi
and the Gs pathways downstream of A1R, whereas the parent
compound lacking a bulky group at the 5 position (NECA) ac-
tivated Gi, Gs, and phospolipase C pathways (Cordeaux et al.,
2004). Future studies will be needed to ascertain whether AMP
and other AMP analogs are functionally selective ligands for A1R
and if this functional selectivity prevents AMP from affecting
physiology or nociceptive behavior directly. Our current data and
previously published data argue that the physiological and in vivo
effects of AMP are indirect. For example, we previously found
that the in vivo antinociceptive effects of AMP were dependent on
ectonucleotidases (Street et al., 2011).
Last, our current findings have clinical implications, particu-
larly given our previous work showing that purified versions of
PAP and NT5E protein have long-lasting (2– 6 d) A1R-dependent
antinociceptive effects when injected intrathecally or peripherally
(Zylka et al., 2008; Sowa et al., 2009; Sowa et al., 2010b; Hurt and
Zylka, 2012). Intrathecal injection of placental alkaline phospha-
tase did not have an acute thermal antinociceptive effect in mice
(Zylka et al., 2008). However, placental alkaline phosphatase is
not TNAP. A recombinant version of TNAP synthesized with a
bone-homing fusion tag (Millán et al., 2008) was recently found
to heal rickets in patients with hypophosphatasia without adverse
drug-related events (Whyte et al., 2012). This remarkable study
highlights the therapeutic potential of enzyme replacement ther-
apy in the setting of a chronic disorder and, more generally, the
therapeutic utility and safety profile of a recombinant enzyme/
ectonucleotidase in humans. Ultimately, it should be possible to
assess the antinociceptive effects of TNAP in preclinical models of
chronic pain once a suitable recombinant version of TNAP is
available (such as one lacking a bone-homing peptide).
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